Cargando…
Targeting Energy Expenditure—Drugs for Obesity Treatment
Obesity and overweight are associated with lethal diseases. In this context, obese and overweight individuals infected by COVID-19 are at greater risk of dying. Obesity is treated by three main pharmaceutical approaches, namely suppressing appetite, reducing energy intake by impairing absorption, an...
Autores principales: | Jimenez-Munoz, Carlos M., López, Marta, Albericio, Fernando, Makowski, Kamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148206/ https://www.ncbi.nlm.nih.gov/pubmed/34066399 http://dx.doi.org/10.3390/ph14050435 |
Ejemplares similares
-
From the past to future: from energy expenditure to energy intake to energy expenditure
por: Müller, M J, et al.
Publicado: (2017) -
Glucagon Regulation of Energy Expenditure
por: Kleinert, Maximilian, et al.
Publicado: (2019) -
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical application
por: Löffler, Mona C., et al.
Publicado: (2021) -
Energy expenditure during overfeeding
por: Joosen, Annemiek MCP, et al.
Publicado: (2006) -
What Is the Impact of Energy Expenditure on Energy Intake?
por: Bosy-Westphal, Anja, et al.
Publicado: (2021)